D-0529-2020 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- December 4, 2019
- Initiation Date
- November 6, 2019
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19320 bottles
Product Description
Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5mL) 474 mL bottle, Rx only Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India NDC 65862-431-74
Reason for Recall
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
Distribution Pattern
nationwide
Code Information
UI1519001-A UI1519002-A UI1519003-A UI1519004-A